Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Xeris Pharmaceuticals
2 followers
MedSchoolCoach
2 followers
Dyno Therapeutics
4 followers
Eikon Therapeutics
3 followers
ParentSquare
2 followers
Cosette Pharmaceuticals
1 follower
Bristol-Myers Squibb
259 followers
Springside Chestnut Hill Academy
35 followers
2U
22 followers
Chicago Public Schools
19 followers
NYU Langone Health
27 followers
Explore companies